AstraZeneca Plc (NASDAQ:AZN) shared on Monday full data from the Bax24 Phase 3 trial of once-daily 2mg baxdrostat versus placebo, on the reduction of ambulatory systolic blood pressure (SBP), as well as safety and tolerability in participants with resistant hypertension.

Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) on Sunday shared results from the pivotal Phase 3 CORE and CORE2 studies of olezarsen for severe hypertriglyceridemia (sHTG), a condition characterized by dangerously high triglyceride (fat) levels.

SOUN posts 68% revenue growth in the third quarter, raises guidance as enterprise AI demand fuels momentum toward breakeven in 2026.

TSN posts a strong Q4 with higher earnings and sales driven by pricing gains, showcasing the strength of its diversified protein portfolio.

PNC commits about $2B to open 300+ new branches by 2030, expanding in key U.S. markets and boosting community access.

RGTI secures $5.7M in Novera system orders and India MOU, but Q3 will test if momentum can turn into real revenue growth.

MKC leans on its CCI program savings to offset cost pressures and drive steady EPS growth in fiscal 2025.

The Zacks Electronics - Miscellaneous Components industry players like TEL, NVT and FN are benefiting from the solid adoption of AI and the democratization of IoT.

SAN DIEGO , Nov. 10, 2025 /PRNewswire/ -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Inspire Medical Systems, Inc. (NYSE: INSP) common stock between August 6, 2024 and August 4, 2025, both dates inclusive (the "Class Period"), have until January 5, 2026 to seek appointment as lead plaintiff of the Inspire Medical class action lawsuit. Captioned City of Pontiac Reestablished General Employees' Retirement System v.

KBR Investors with Losses Encouraged to Contact Hagens Berman Before Nov. 18th Deadline San Francisco, California--(Newsfile Corp. - November 10, 2025) - A pending class-action lawsuit targeting KBR, Inc. (NYSE: KBR) alleges that the company made misleading statements to investors in the weeks leading up to the abrupt cancellation of a major military contract which negatively impacted the company's business prospects. The lawsuit seeks to represent investors who purchased or otherwise acquired KBR securities between May 6, 2025 and June 19, 2025.

Surgery Partners, Inc. ( SGRY ) Q3 2025 Earnings Call November 10, 2025 8:30 AM EST Company Participants David Doherty - Executive VP & CFO J. Evans - CEO & Director Conference Call Participants Brian Tanquilut - Jefferies LLC, Research Division Joanna Gajuk - BofA Securities, Research Division Benjamin Rossi - JPMorgan Chase & Co, Research Division Matthew Gillmor - KeyBanc Capital Markets Inc., Research Division Benjamin Hendrix - RBC Capital Markets, Research Division Andrew Mok - Barclays Bank PLC, Research Division Sarah James - Cantor Fitzgerald & Co., Research Division Benjamin Mayo - Leerink Partners LLC, Research Division William …

Webcast Recording and Symposium Slides Now Available LAWRENCEVILLE, N.J., Nov. 10, 2025 (GLOBE NEWSWIRE) -- IMUNON , Inc. (Nasdaq: IMNN), a clinical-stage company in Phase 3 development with its DNA-mediated immunotherapy, today hosted a compelling public webcast, where cancer key opinion leaders, principal investigators from the Phase 3 OVATION 3 and Phase 2 minimal residual disease (MRD) trials, clinicians, statistical experts and IMUNON executives shared critical insights into the disease and translational data, along with compelling clinical data highlighting the significant potential of IMNN-001 for women with advanced ovarian cancer.

ATHENS, Greece, Nov. 10, 2025 (GLOBE NEWSWIRE) -- EuroDry Ltd. (NASDAQ: EDRY, the “Company” or “EuroDry”), an owner and operator of drybulk vessels and provider of seaborne transportation for drybulk cargoes, announced today that it will release its financial results for the third quarter ended September 30, 2025, on November 13, 2025 before market opens in New York.

New Agentic AI Platform and AI Capabilities Help Customers Break Down Data Silos to Unlock Productivity — A Force Multiplier in Solving Real World Customer Problems at Scale LAS VEGAS , Nov. 10, 2025 /PRNewswire/ -- Trimble (Nasdaq: TRMB) today gave attendees of its annual user conference, Trimble Dimensions , a firsthand look at artificial intelligence (AI) innovation and the company's vision for accelerating the development and expansion of agentic AI in engineering and construction workflows. At the core of recent initiatives is Trimble's agentic AI platform, a collection of core services, security frameworks, and tools used by Trimble to …

SENEA posts stronger second-quarter fiscal 2026 results as higher vegetable volumes and margin gains boost overall profitability.

Ford Motor Co. faces weak U.S. demand for electric pickups, with possible cancellation of the F-150 Lightning reflecting a broader EV market slowdown. F's rushed BEV strategy led to heavy losses, with $13 billion lost on BEVs since 2023 and uncertainty about future capital requirements. The company is pivoting to hybrids and extended-range electric vehicles, delaying new BEV models and reconsidering its all-electric truck ambitions amid regulatory and market challenges.

The company's struggles in China are part of the reason Tesla is likely to report another annual sales decline.

MannKind Corporation ( MNKD ) Discusses Discontinuation of ICoN-1 Phase III Trial for Nebulized Clofazimine in NTM Lung Disease November 10, 2025 9:00 AM EST Company Participants Michael Castagna - CEO & Director Conference Call Participants Olivia Brayer - Cantor Fitzgerald & Co., Research Division Benjamin Burnett - Wells Fargo Securities, LLC, Research Division Faisal Khurshid - Leerink Partners LLC, Research Division Brandon Folkes - H.C. Wainwright & Co, LLC, Research Division Presentation Operator Good morning, and welcome to MannKind Corporation's investor call to discuss a clinical trial update.

Townsquare Media, Inc. ( TSQ ) Q3 2025 Earnings Call November 10, 2025 8:00 AM EST Company Participants Claire Messner - Executive VP of IR & Corporate Communications Bill Wilson - CEO & Director Stuart Rosenstein - Executive VP & CFO Conference Call Participants Michael Kupinski - NOBLE Capital Markets, Inc., Research Division Patrick Sholl - Barrington Research Associates, Inc., Research Division Presentation Operator Good morning, and welcome to Townsquare Media's Third Quarter 2025 Conference Call. As a reminder, today's call is being recorded, and your participation implies consent to the recording.

VEON Ltd. ( VEON ) Q3 2025 Earnings Call November 10, 2025 7:00 AM EST Company Participants Anand Ramachandran - Corporate Development Officer Muhterem Terzioglu - Group CEO & Director Burak Ozer - Group Chief Financial Officer Conference Call Participants Jesse Sobelson - BTIG, LLC, Research Division Nicholas Paton - Edison Investment Research Limited Adrian Francis Cundy Ahmed Mostafa - Inam FZE, Research Division Vincent Fernando Ali Zaidi - Inam FZE, Research Division Matthew Harrigan - The Benchmark Company, LLC, Research Division Presentation Anand Ramachandran Corporate Development Officer Hello. Good afternoon, and good morning to everyone.